175 related articles for article (PubMed ID: 33505217)
21. Distribution of distinct subsets of circulating T follicular helper cells in Kawasaki disease.
Xu M; Jiang Y; Wang J; Liu D; Wang S; Yi H; Yang S
BMC Pediatr; 2019 Jan; 19(1):43. PubMed ID: 30704426
[TBL] [Abstract][Full Text] [Related]
22. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
Sun Y; Liu J; Geng Z; Tao Y; Zheng F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2020 Mar; 18(1):23. PubMed ID: 32183825
[TBL] [Abstract][Full Text] [Related]
23. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
Jin J; Wang J; Lu Y; Fan Z; Huang N; Ma L; Yu H
Indian J Pediatr; 2019 Mar; 86(3):250-255. PubMed ID: 30159809
[TBL] [Abstract][Full Text] [Related]
24. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm.
Weng H; Peng Y; Pei Q; Jing F; Yang M; Yi Q
Pediatr Res; 2021 Feb; 89(3):569-573. PubMed ID: 32316027
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions.
Wang L; Yang Y; Cui Q; Cui Y; Li Q; Che X; Wang C; Quan P; Hu X
J Investig Med; 2021 Jan; 69(1):13-19. PubMed ID: 33004469
[TBL] [Abstract][Full Text] [Related]
26. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
[TBL] [Abstract][Full Text] [Related]
27. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
Si F; Wu Y; Gao F; Feng S; Liu R; Yi Q
Clin Exp Med; 2017 Nov; 17(4):451-457. PubMed ID: 28108813
[TBL] [Abstract][Full Text] [Related]
28. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J; Liu P; Hu W; Xu Y; Deng J
Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
[TBL] [Abstract][Full Text] [Related]
29. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S; Yıldız K; Acarı C; Dundar HA; Kır M; Ünsal E
Turk J Pediatr; 2020; 62(1):1-9. PubMed ID: 32253860
[TBL] [Abstract][Full Text] [Related]
30. The expression and significance of serum caveolin-1 in patients with Kawasaki disease.
Zhu F; Huang J; Wang X; Li P; Yan Y; Zheng Y; He Y; Wu T; Ren Y; Wu R
Chin J Physiol; 2020; 63(2):90-94. PubMed ID: 32341235
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
32. Retinol-binding protein 4 (RBP4) and high sensitivity C-reactive protein (hs-CRP) levels in patients with diminished ovarian reserve (DOR): a cross-sectional study.
Zou W; Wang Z; Xia J; Yang J
Reprod Biol Endocrinol; 2020 Nov; 18(1):111. PubMed ID: 33198782
[TBL] [Abstract][Full Text] [Related]
33. Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.
Luo L; Feng S; Wu Y; Su Y; Jing F; Yi Q
Pediatr Infect Dis J; 2019 Jan; 38(1):89-94. PubMed ID: 29601451
[TBL] [Abstract][Full Text] [Related]
34. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B
Int Immunopharmacol; 2020 Dec; 89(Pt A):107037. PubMed ID: 33242833
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Lai TJ; Tang CW; Lin CC; Ho TY; Liou HH; Ger LP
J Chin Med Assoc; 2013 Aug; 76(8):438-45. PubMed ID: 23769880
[TBL] [Abstract][Full Text] [Related]
36. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S; Kimura M; Ishikawa T; Ohzeki T
Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
[TBL] [Abstract][Full Text] [Related]
37. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
Zhao CN; Du ZD; Gao LL
Chin Med J (Engl); 2016 Apr; 129(8):922-8. PubMed ID: 27064036
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic role of AIM2 in Kawasaki disease.
Wang Z; Wang Q; Jin J; Rong X; Wu T; Qiu H; Wu R
Clin Exp Med; 2021 Feb; 21(1):41-47. PubMed ID: 33079289
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
Shimizu M; Mizuta M; Usami M; Inoue N; Sakakibara Y; Yamada K; Konishi M; Ohta K; Yachie A
Cytokine; 2018 Aug; 108():168-172. PubMed ID: 29625336
[TBL] [Abstract][Full Text] [Related]
40. Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions.
Furui J; Ishii M; Ikeda H; Muta H; Egami K; Sugahara Y; Himeno W; Akagi T; Kato H; Matsuishi T
Acta Paediatr; 2002; 91(11):1183-8. PubMed ID: 12463316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
